2026 Symposium Chairs
Honorary Chair
Arno J. Mundt, MD, FACRO, FASTRO, Distinguished Professor and Chair, Radiation Medicine & Applied Sciences, Member, Executive Governing Committee, Moores Cancer Center, UC San Diego
Committee Chair
Ida Deichaite, PhD, Assistant Professor, Department of Radiation Medicine and Applied Sciences, Center for Precision Radiation Medicine, UC San Diego
Committee Co-Chair
Andrew Sharabi, MD, PhD, Associate Professor, Director, Center for Precision Radiation Medicine, Jacobs Chancellor’s Endowed Chair, Director, Moores Cancer Center Radiation Medicine Core Facility, Radiation Medicine and Applied Sciences, UC San Diego
2026 Symposium Committee
Phil Chamberlain, DPhil, Co-Founder, President, and CEO, Neomorph
Christine Chung, MD, Chair and Professor, Department of Radiology, UC San Diego
Ezra Cohen, MD, Chief Medical Officer, Oncology, Tempus
J. Silvio Gutkind, PhD, Chair and Professor, Department of Pharmacology, Moores Cancer Center, UC San Diego
Jake Haling, PhD, Head of Oncology Drug Discovery, San Diego, Novartis Institutes for Biomedical Research
Hunter Reed, MBA, Senior Vice President, Strategic Marketing Director, Alexandria Venture Investments, Alexandria Real Estate Equities, Inc.
Nicole Steinmetz, PhD, Vice Chair, Department of NanoEngineering, Center for Nano-ImmunoEngineering, Center for Engineering in Cancer, Moores Cancer Center, Center for Precision Immunotherapy, UC San Diego
2026 Speakers, Panelists, and Session Chairs
Lyudmila Bazhenova, MD, Clinical Professor, Division of Medical Oncology, Department of Medicine, Director, Hematology Oncology Training Program, Moores Cancer Center, UC San Diego
Danny Beck, Vice President, Business Development, Enlaza Therapeutics
Aaron Boussina, PhD, Assistant Professor, Department of Medicine, UC San Diego
Phil Chamberlain, DPhil, Co-Founder, President, and CEO, Neomorph
Helio Costa, PhD, Head of Therapeutics, Natera
Nathan Fowler, MD, Chief Medical Officer, BostonGene Corporation
Jake Haling, PhD, Head of Oncology Drug Discovery, San Diego, Novartis Institutes for Biomedical Research
Lawrence Hamann, PhD, Co-Founder, President, and CEO, Interdict Bio
Jingjing Jiang, PhD, Vice President, Translational Research, Revolution Medicines
Gary Li, PhD, Chief Strategy Officer, AdvanCell
Sandip Patel, MD, Professor of Medicine, Deputy Director, Sanford Stem Cell Clinical Center, Moores Cancer Center, UC San Diego
Zhengtao Qin, PhD, US Medical Lead, Prostate Cancer, AstraZeneca
Rebecca Rakow-Penner, MD, PhD, Associate Professor, Department of Radiology, UC San Diego
John Reed, MD, PhD, Executive Vice President, Innovative Medicine, R&D, Executive Committee Member, Johnson & Johnson
Andrew Sharabi, MD, PhD, Associate Professor, Director, Center for Precision Radiation Medicine, Jacobs Chancellor’s Endowed Chair, Director, Moores Cancer Center Radiation Medicine Core Facility, Radiation Medicine and Applied Sciences, UC San Diego
Jeffrey Stafford, PhD, President and CEO, 858 Therapeutics
Nicole Steinmetz, PhD, Vice Chair, Department of NanoEngineering, Center for Nano-ImmunoEngineering, Center for Engineering in Cancer, Moores Cancer Center, Center for Precision Immunotherapy, UC San Diego
Rebekah White, MD, FACS, Professor of Surgery, Division of Surgical Oncology, Department of Surgery, Moores Cancer Center, UC San Diego
Fredrik Wiklund, CEO, Bright Peak Therapeutics
Troy Wilson, PhD, JD, President, CEO and Chairman, Kura Oncology
Jin Zhang, PhD, Vice Chair and Professor, Department of Pharmacology, Moores Cancer Center, UC San Diego
TBD, Inhibrx
Archived Agendas
The success of the Symposium is made possible by our dynamic sessions featuring distinguished leaders from industry and academia.
View Past Agendas: 2025 Agenda (PDF) | 2024 Agenda (PDF) | 2023 Agenda (PDF)
2022 Agenda (PDF) | 2021 Agenda (PDF) |
2020 Agenda (PDF) | 2019 Agenda (PDF)